Pharmaceutical

Image

Global Oncology Nutrition Market – Industry Trends and Forecast to 2030

  • Pharmaceutical
  • Upcoming Report
  • Oct 2023
  • Global
  • 350 Pages
  • No of Tables: 60
  • No of Figures: 220

Global Oncology Nutrition Market – Industry Trends and Forecast to 2030

Market Size in USD Billion

CAGR - % Diagram

Diagram Forecast Period 2022–2030
Diagram Market Size (Base Year) USD 1974.75 Million
Diagram Market Size (Forecast Year) USD 3630.83 Million
Diagram CAGR %

Global Oncology Nutrition Market, By Cancer Type (Head and Neck Cancer, Stomach and Gastrointestinal Cancers, Esophageal Cancer, Pancreatic Cancer, Liver Cancer, Blood Cancer, Breast Cancer, Lung Cancer, Others), Nutrition (Enteral Nutrition, Parenteral Nutrition), Formula (Standard Formula, Elemental Formula, Specialized Formula), Route of Administration (Oral, Parenteral), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) – Industry Trends and Forecast to 2030.

Oncology Nutrition Market Analysis and Size

The rise in the prevalence of cancer is the major driver resulting in the expansion of market’s growth. Another significant factor influencing the growth rate of oncology nutrition market is the rising healthcare expenditure. Additionally, rise in the number of clinical trials, rapid product origination and increase in the focus on enteral nutrition will cushion the growth rate of oncology nutrition market. Moreover, the rise in the research and development activities and launch of new products for the nutrition of oncology patients will provide beneficial opportunities for the oncology nutrition market in the forecast period of 2023-2030. Also, developments of elemental formulas and emerging new markets will escalate the growth rate global oncology nutrition market in future.

Data Bridge Market Research analyses that the global oncology nutrition market, which was USD 1974.75 million in 2022, is expected to reach USD 3630.83 million by 2030, and is expected to undergo a CAGR of 7.91% during the forecast period 2023-2030. This indicates that the Head and Neck Cancer segment dominates the cancer type segment of the global oncology nutrition market owing to the advancements in technology. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Oncology Nutrition Market Scope and Segmentation

Report Metric

Details

Forecast Period

2023 to 2030

Base Year

2022

Historic Years

2021 (Customizable to 2015-2020)

Quantitative Units

Revenue in USD Million, Volumes in Units, Pricing in USD

Segments Covered

 Cancer Type (Head and Neck Cancer, Stomach and Gastrointestinal Cancers, Esophageal Cancer, Pancreatic Cancer, Liver Cancer, Blood Cancer, Breast Cancer, Lung Cancer, Others), Nutrition (Enteral Nutrition, Parenteral Nutrition), Formula (Standard Formula, Elemental Formula, Specialized Formula), Route of Administration (Oral, Parenteral), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

Market Players Covered

FMC Corporation (U.S.), Danone  (India), Abbott (U.S.), Aceto (U.S.), B. Braun Melsungen AG (Germany),Baxter (U.S.), Fresenius Kabi AG (Germany),Global Health Products, Inc. (U.S.),  Hormel Foods Corporation (U.S.), Mead Johnson & Company, LLC (U.S.), Meiji Holdings Co., Ltd (Japan), Nestlé S.A.( Switzerland), BioSig Technologies, Inc. (U.S.), Auris Health, Inc. (U.S.)

Market Opportunities

  • Rising Technology Advancement in Cancer Treatment
  • Growing awareness of the importance of nutrition in cancer care
  • Rising healthcare expenditure

Market Definition

Cancer is characterised by the unregulated proliferation of aberrant cells. Tumor cells or malignant cells are the names given to these cells. Oncology is the branch of medicine that deals with the prevention, treatment and diagnosis of cancer. Oncology nutrition refers to the nutrition and diet that a cancer patient consumes during and after therapy. Nutrition is a crucial therapy during cancer treatment and plays a key influence in numerous aspects of cancer development. Appropriate diet can help cancer patients maintain a healthy weight and body composition, resulting in improved healing and a higher quality of life.

Global Oncology Nutrition Market Dynamics

Drivers

  • Increasing Prevalence of Cancer

The rising incidence of cancer worldwide is a major driver for the global oncology nutrition market. Cancer patients often experience malnutrition and weight loss due to the disease itself or its treatments, creating a demand for specialized nutrition products.

  • Growing Awareness of the Importance of Nutrition in Cancer Care

There is a growing recognition among healthcare professionals about the significant impact of nutrition on cancer treatment outcomes. This has led to increased emphasis on personalized nutrition plans for cancer patients, driving the demand for oncology nutrition products.

  • Focus on Supportive Care in Cancer Management

Supportive care, including nutritional support, is an integral part of comprehensive cancer management. Oncology nutrition plays a crucial role in managing treatment-related side effects, improving quality of life, and enhancing treatment outcomes.

Opportunities

  • Advancements in Cancer Treatments

 Advancements in cancer treatments, such as chemotherapy, radiation therapy, and targeted therapies, have improved survival rates. However, these treatments can cause side effects like appetite loss, taste changes, and difficulty swallowing, creating a need for specialized nutrition support.

  • Rising Healthcare Expenditure

Increasing healthcare expenditure, particularly in emerging economies, has led to improved access to cancer treatments and supportive care services. This has contributed to the growth of the global oncology nutrition market.

Restraints/Challenges

  • High Cost of Specialized Oncology Nutrition Products

Oncology-specific nutrition products can be expensive compared to regular nutritional supplements. The high cost may limit affordability and accessibility, particularly in lower-income regions, leading to restricted market growth.

  • Limited Reimbursement Coverage

In some healthcare systems, reimbursement coverage for oncology nutrition products may be limited or non-existent. This can pose challenges for patients and healthcare providers in accessing and utilizing these specialized products, affecting market growth

This global oncology nutrition market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global oncology nutrition market Contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Development

  • On July 2021, Nestlé Health Science, a leading player in the oncology nutrition market, announced the expansion of its portfolio with the launch of two new products: Resource® ThickenUp Clear Oncology and Resource ThickenUp Clear Oncology Ready-To-Drink. These products are designed to provide hydration and nutrition support for cancer patients with swallowing difficulties
  • On June, 2021, Abbott, a global healthcare company, introduced ProSure Oncology in India. ProSure Oncology is a specialized nutritional supplement designed to support the nutritional needs of cancer patients undergoing treatment. It is formulated with high-quality protein, omega-3 fatty acids, and a blend of vitamins and minerals

Global Oncology Nutrition Market Scope

The global oncology nutrition market is segmented on the basis of cancer type, nutrition, and formula, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Cancer Type

  • Head and Neck Cancer
  •  Stomach and Gastrointestinal Cancers
  •  Esophageal Cancer
  •  Pancreatic Cancer
  •  Liver Cancer
  •  Blood Cancer
  •  Breast Cancer
  •  Lung Cancer
  •  Others

Nutrition

  • Enteral Nutrition
  • Parenteral Nutrition

Formula

  • Standard Formula
  •  Elemental Formula
  •  Specialized Formula

Route of Administration

  • Oral
  • Parenteral

 End-Users

  • Hospitals
  • Homecare
  • Specialty Clinics
  • Others

Distribution Channel

  • Hospital Pharmacy
  • Online Pharmacy
  • Retail Pharmacy

Global Oncology Nutrition Market Regional Analysis/Insights

The global oncology nutrition market is analysed and market size insights and trends are provided by country, cancer type, nutrition, formula, route of administration, end-users and distribution channel as referenced above.

The countries covered in the global oncology nutrition market  report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the global oncology nutrition market because of the strong base of healthcare facilities, strong presence of major players in the market, rising demand of the  Oncology Nutrition products and rising number of research activities in this region.   

Asia-Pacific is expected to witness significant growth during the forecast period of 2023 to 2030 due to the increase in government initiatives to promote awareness, rise in medical tourism, growing research activities in the region, availability of massive untapped markets, large population pool, and the growing demand for quality healthcare in the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

The global oncology nutrition market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for global oncology nutrition market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the global oncology nutrition market. The data is available for historic period 2015-2020.

Competitive Landscape and Global Oncology Nutrition Market Share Analysis

The global oncology nutrition market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global oncology nutrition market.

Some of the major players operating in the global oncology nutrition market are:

  • FMC Corporation (U.S.)
  •  Danone (India)
  •  Abbott (U.S.)
  •  Aceto (U.S.)
  •  B. Braun Melsungen AG (Germany)
  • Baxter (U.S.)
  •  Fresenius Kabi AG (Germany)
  • Global Health Products, Inc. (U.S.)
  •   Hormel Foods Corporation (U.S.)
  •  Mead Johnson & Company, LLC (U.S.)
  •  Meiji Holdings Co., Ltd (Japan)
  •  Nestlé S.A. (Switzerland)
  •  BioSig Technologies, Inc. (U.S.)
  •  Auris Health, Inc. (U.S.)


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

FREQUENTLY ASK QUESTIONS

The Oncology Nutrition Market will be worth USD 3630.83 million by 2030.
The Oncology Nutrition Market growth rate is 7.91% during the forecast period.
Increasing Prevalence of Cancer, Growing Awareness of the Importance of Nutrition in Cancer Care and Focus on Supportive Care in Cancer Management are the growth drivers of the Oncology Nutrition Market.
The cancer type, nutrition, and formula, route of administration, end-users and distribution channel are the factors on which the Oncology Nutrition Market research is based.
Nestlé Health Science, a leading player in the oncology nutrition market, announced the expansion of its portfolio with the launch of two new products & Abbott, a global healthcare company, introduced ProSure Oncology in India. ProSure Oncology is a specialized nutritional supplement designed to support the nutritional needs of cancer patients undergoing treatment are the latest developments in the Oncology Nutrition Market.
Free Sample Report

CHOOSE LICENCE TYPE

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials